NASDAQ:MDXG - MiMedx Group Stock Price, Price Target & More

$7.32 -0.02 (-0.27 %)
(As of 04/19/2018 11:00 AM ET)
Previous Close$7.34
Today's Range$7.23 - $7.42
52-Week Range$6.05 - $18.25
Volume256,082 shs
Average Volume3.20 million shs
Market Capitalization$816.11 million
P/E Ratio61.17
Dividend YieldN/A
Beta1.62

About MiMedx Group (NASDAQ:MDXG)

MiMedx Group logoMiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

Receive MDXG News and Ratings via Email

Sign-up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MDXG
CUSIPN/A
Phone770-651-9100

Debt

Debt-to-Equity RatioN/A
Current Ratio3.25%
Quick Ratio2.95%

Price-To-Earnings

Trailing P/E Ratio61.17
Forward P/E Ratio31.83
P/E Growth0.95

Sales & Book Value

Annual Sales$245.01 million
Price / Sales3.32
Cash Flow$0.1810 per share
Price / Cash40.44
Book Value$1.21 per share
Price / Book6.05

Profitability

EPS (Most Recent Fiscal Year)$0.12
Net Income$11.97 million
Net Margins11.64%
Return on Equity17.49%
Return on Assets12.69%

Miscellaneous

Employees690
Outstanding Shares111,040,000

How to Become a New Pot Stock Millionaire

MiMedx Group (NASDAQ:MDXG) Frequently Asked Questions

What is MiMedx Group's stock symbol?

MiMedx Group trades on the NASDAQ under the ticker symbol "MDXG."

How will MiMedx Group's stock buyback program work?

MiMedx Group declared that its board has authorized a share repurchase plan on Wednesday, December 13th 2017, which permits the company to repurchase $10,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's board believes its shares are undervalued.

How were MiMedx Group's earnings last quarter?

MiMedx Group, Inc. (NASDAQ:MDXG) posted its quarterly earnings results on Thursday, October, 26th. The medical equipment provider reported $0.08 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.08. The medical equipment provider earned $84.60 million during the quarter, compared to the consensus estimate of $84.60 million. MiMedx Group had a return on equity of 17.49% and a net margin of 11.64%. The company's revenue for the quarter was up 31.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.06 earnings per share. View MiMedx Group's Earnings History.

What price target have analysts set for MDXG?

5 equities research analysts have issued twelve-month target prices for MiMedx Group's shares. Their predictions range from $9.00 to $21.00. On average, they expect MiMedx Group's share price to reach $14.75 in the next year. View Analyst Ratings for MiMedx Group.

What are Wall Street analysts saying about MiMedx Group stock?

Here are some recent quotes from research analysts about MiMedx Group stock:
  • 1. Needham & Company LLC analysts commented, "This morning (3/15/18), MDXG issued a press release announcing: 1) management expects 1Q18 revenue to exceed the high end of their guidance range and reiterates their 2018 guidance and 2) the U.S. Department of Justice (DOJ) is reviewing the SEC investigation matters. While MDXG’s business appears to be performing well despite the controversy swirling around the company, we believe investors may continue to heavily discount the fundamentals until more is known about the outcome of the Audit Committee’s investigation, the SEC investigation, and the DOJ review." (3/15/2018)
  • 2. According to Zacks Investment Research, "MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Innovations in Regenerative Biomaterials is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant. " (12/8/2017)

Are investors shorting MiMedx Group?

MiMedx Group saw a increase in short interest during the month of March. As of March 29th, there was short interest totalling 49,149,884 shares, an increase of 11.1% from the March 15th total of 44,229,721 shares. Based on an average daily volume of 2,564,855 shares, the short-interest ratio is presently 19.2 days. Approximately 47.9% of the shares of the stock are sold short.

Who are some of MiMedx Group's key competitors?

Who are MiMedx Group's key executives?

MiMedx Group's management team includes the folowing people:
  • Mr. Parker H. Petit, Chairman and Chief Exec. Officer (Age 79)
  • Mr. William Charles Taylor, Pres, Chief Operating Officer and Director (Age 50)
  • Mr. Michael J. Senken, CFO, Principal Accounting Officer & VP (Age 60)
  • Ms. Alexandra O. Haden, Gen. Counsel and Sec. (Age 43)
  • Dr. Thomas J. Koob, Chief Scientific Officer (Age 69)

Has MiMedx Group been receiving favorable news coverage?

Media stories about MDXG stock have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. MiMedx Group earned a media sentiment score of 0.17 on Accern's scale. They also gave media stories about the medical equipment provider an impact score of 46.37 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are MiMedx Group's major shareholders?

MiMedx Group's stock is owned by many different of institutional and retail investors. Top institutional investors include STATE STREET CORP (10.01%). Company insiders that own MiMedx Group stock include Parker H Petit and William Charles Taylor. View Institutional Ownership Trends for MiMedx Group.

How do I buy shares of MiMedx Group?

Shares of MDXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MiMedx Group's stock price today?

One share of MDXG stock can currently be purchased for approximately $7.32.

How big of a company is MiMedx Group?

MiMedx Group has a market capitalization of $816.11 million and generates $245.01 million in revenue each year. The medical equipment provider earns $11.97 million in net income (profit) each year or $0.12 on an earnings per share basis. MiMedx Group employs 690 workers across the globe.

How can I contact MiMedx Group?

MiMedx Group's mailing address is 1775 W OAK COMMONS COURT NE, MARIETTA GA, 30062. The medical equipment provider can be reached via phone at 770-651-9100 or via email at [email protected]


MarketBeat Community Rating for MiMedx Group (MDXG)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  302 (Vote Outperform)
Underperform Votes:  166 (Vote Underperform)
Total Votes:  468
MarketBeat's community ratings are surveys of what our community members think about MiMedx Group and other stocks. Vote "Outperform" if you believe MDXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDXG will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MiMedx Group (NASDAQ:MDXG) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for MiMedx Group in the last 12 months. Their average twelve-month price target is $14.75, suggesting that the stock has a possible upside of 101.50%. The high price target for MDXG is $21.00 and the low price target for MDXG is $9.00. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.202.202.502.50
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $14.75$14.75$17.00$14.8333
Price Target Upside: 101.50% upside107.45% upside41.78% upside10.26% downside

MiMedx Group (NASDAQ:MDXG) Consensus Price Target History

Price Target History for MiMedx Group (NASDAQ:MDXG)

MiMedx Group (NASDAQ:MDXG) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2018Needham & Company LLCReiterated RatingHoldHighView Rating Details
2/27/2018Craig HallumReiterated RatingBuyLowView Rating Details
2/23/2018Lake Street CapitalDowngradeBuy -> Hold$9.00LowView Rating Details
12/1/2017Piper JaffrayReiterated RatingBuy$18.00LowView Rating Details
5/23/2017First AnalysisDowngradeEqual Weight -> Underweight$11.00HighView Rating Details
12/12/2016UBSInitiated CoverageSell$9.00N/AView Rating Details
11/7/2016AegisInitiated CoverageBuy$12.00N/AView Rating Details
6/29/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

MiMedx Group (NASDAQ:MDXG) Earnings History and Estimates Chart

Earnings by Quarter for MiMedx Group (NASDAQ:MDXG)

MiMedx Group (NASDAQ:MDXG) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.06$0.06$0.06

MiMedx Group (NASDAQ MDXG) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017Q3 2017$0.08$0.08$84.60 million$84.60 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.0680$0.07$74.22 million$76.40 millionViewN/AView Earnings Details
4/28/2017Q1 2017$0.0680$0.07$72.60 million$72.60 millionViewN/AView Earnings Details
2/23/2017Q416$0.08$0.05$71.13 million$69.90 millionViewListenView Earnings Details
10/27/2016Q316$0.06$0.06$63.18 million$64.40 millionViewListenView Earnings Details
7/26/2016Q216$0.07$0.05$56.49 million$57.00 millionViewListenView Earnings Details
4/25/2016Q116$0.05$0.04$54.05 million$53.40 millionViewListenView Earnings Details
2/23/2016Q415$0.06$0.12$51.84 million$51.80 millionViewListenView Earnings Details
10/29/2015Q315$0.06$0.06$48.61 million$49.00 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$45.03 million$45.68 millionViewListenView Earnings Details
4/27/2015Q1$0.03$0.04$40.77 millionViewListenView Earnings Details
2/26/2015Q414$0.03$0.03$38.15 million$39.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02$0.03$33.50 million$33.50 millionViewListenView Earnings Details
4/25/2014Q114($0.02)($0.01)$19.09 million$19.60 millionViewListenView Earnings Details
2/26/2014Q4($0.01)($0.04)$18.31 million$18.00 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.01)($0.01)$12.94 million$13.52 millionViewListenView Earnings Details
5/1/2013Q1 2013($0.02)($0.02)$11.34 million$11.56 millionViewListenView Earnings Details
3/7/2013Q4 2012($0.01)($0.01)ViewN/AView Earnings Details
10/29/2012Q3 2012($0.05)ViewN/AView Earnings Details
5/2/2012Q1 2012($0.02)ViewN/AView Earnings Details
2/28/2012Q4 2011($0.25)ViewN/AView Earnings Details
10/26/2011Q3 2011($0.02)ViewN/AView Earnings Details
7/25/2011Q2 2011($0.03)ViewN/AView Earnings Details
4/26/2011Q1 2011($0.05)ViewN/AView Earnings Details
3/28/2011Q4 2010($0.04)ViewN/AView Earnings Details
10/26/2010Q3 2010($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

MiMedx Group (NASDAQ:MDXG) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MiMedx Group (NASDAQ MDXG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.40%
Institutional Ownership Percentage: 79.97%
Insider Trading History for MiMedx Group (NASDAQ:MDXG)
Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

MiMedx Group (NASDAQ MDXG) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2017William Charles TaylorInsiderSell80,000$14.52$1,161,600.00547,424View SEC Filing  
5/25/2017William Charles TaylorInsiderSell26,571$13.74$365,085.54533,612View SEC Filing  
4/27/2017William Charles TaylorInsiderSell26,000$11.40$296,400.00540,460View SEC Filing  
9/6/2016William Charles TaylorInsiderSell20,400$7.55$154,020.00566,566View SEC Filing  
8/1/2016William Charles TaylorInsiderSell29,112$7.55$219,795.60612,316View SEC Filing  
6/16/2016William Charles TaylorCOOSell24,333$7.52$182,984.16616,078View SEC Filing  
5/20/2016Parker H PetitCEOBuy20,000$6.99$139,800.005,009,121View SEC Filing  
5/17/2016Parker H PetitCEOBuy30,000$6.82$204,600.004,989,121View SEC Filing  
5/13/2016Parker H PetitCEOBuy40,000$6.75$270,000.004,959,121View SEC Filing  
5/12/2016Parker H PetitCEOBuy50,000$6.74$337,000.004,919,121View SEC Filing  
11/13/2015Charles Robert EvansDirectorBuy10,000$7.84$78,400.0031,878View SEC Filing  
11/10/2015Parker H PetitCEOBuy131,925$7.58$999,991.505,026,821View SEC Filing  
10/30/2015Alexandra O. HadenGeneral CounselBuy4,150$7.92$32,868.0040,528View SEC Filing  
5/28/2015Larry W PapasanDirectorSell5,958$10.09$60,116.22View SEC Filing  
5/18/2015William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
10/31/2014William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
7/1/2014William Charles TaylorCOOSell150,000$7.50$1,125,000.00View SEC Filing  
1/17/2014Parker PetitCEOSell150,000$8.28$1,242,000.00View SEC Filing  
8/28/2013William Charles TaylorCOOSell9,800$6.15$60,270.00View SEC Filing  
8/7/2013William Charles TaylorCOOSell183,765$6.21$1,141,180.65View SEC Filing  
5/16/2013Steve GorlinDirectorSell30,000$6.46$193,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

MiMedx Group (NASDAQ MDXG) News Headlines

Source:
DateHeadline
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against MiMedx Group Inc. (MDXG)Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against MiMedx Group Inc. (MDXG)
finance.yahoo.com - April 19 at 8:33 AM
MDXG INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018MDXG INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - April 18 at 5:31 PM
MiMedx Group, Inc. (MDXG) Receives Consensus Rating of "Hold" from AnalystsMiMedx Group, Inc. (MDXG) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 18 at 11:30 AM
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. (Nasdaq: MDXG) To Contact The FirmFINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. (Nasdaq: MDXG) To Contact The Firm
finance.yahoo.com - April 18 at 8:33 AM
Investors Buy High Volume of MiMedx Group Put Options (MDXG)Investors Buy High Volume of MiMedx Group Put Options (MDXG)
www.americanbankingnews.com - April 18 at 7:04 AM
IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The FirmIMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The Firm
finance.yahoo.com - April 17 at 8:54 AM
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - April 16 at 5:08 PM
DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The FirmDEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The Firm
finance.yahoo.com - April 14 at 4:59 PM
MIMEDX SHAREHOLDER ALERT: CLAIMSFILER REMINDS...MIMEDX SHAREHOLDER ALERT: CLAIMSFILER REMINDS...
www.benzinga.com - April 14 at 8:42 AM
Global Advanced Wound Care Market Opportunities 2018: MiMedx Group, 3 M Company, Medtronic , Kinetic Concepts, Integra Life SciencesGlobal Advanced Wound Care Market Opportunities 2018: MiMedx Group, 3 M Company, Medtronic , Kinetic Concepts, Integra Life Sciences
www.marketwatch.com - April 13 at 8:43 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - April 12 at 5:20 PM
MDXG SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018MDXG SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - April 12 at 5:20 PM
MiMedx Group, Inc. (MDXG) Short Interest UpdateMiMedx Group, Inc. (MDXG) Short Interest Update
www.americanbankingnews.com - April 12 at 2:17 AM
Safirstein Metcalf LLP Reminds Investors that Class Actions have been Filed Against MiMedx Group, Inc. – MDXGSafirstein Metcalf LLP Reminds Investors that Class Actions have been Filed Against MiMedx Group, Inc. – MDXG
feeds.benzinga.com - April 11 at 7:10 PM
MiMedx Group (MDXG) Upgraded at BidaskClubMiMedx Group (MDXG) Upgraded at BidaskClub
www.americanbankingnews.com - April 10 at 9:26 PM
DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The FirmDEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. and Reminds Investors With Losses to Contact The Firm
finance.yahoo.com - April 10 at 5:16 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXGINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXG
finance.yahoo.com - April 9 at 5:07 PM
Hagens Berman Reminds MiMedx Group Investors of the April 25, 2018 Lead Plaintiff Deadline in the Pending ...Hagens Berman Reminds MiMedx Group Investors of the April 25, 2018 Lead Plaintiff Deadline in the Pending ...
www.globenewswire.com - April 8 at 9:48 AM
Zacks Investment Research Lowers MiMedx Group (MDXG) to SellZacks Investment Research Lowers MiMedx Group (MDXG) to Sell
www.americanbankingnews.com - April 7 at 7:17 PM
APRIL 25 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. And Reminds Investors With Losses To Contact The FirmAPRIL 25 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MiMedx Group Inc. And Reminds Investors With Losses To Contact The Firm
finance.yahoo.com - April 7 at 4:18 PM
Hagens Berman Reminds MiMedx Group Investors of the April 25, 2018 Lead Plaintiff Deadline in the Pending Securities Class ActionHagens Berman Reminds MiMedx Group Investors of the April 25, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action
finance.yahoo.com - April 6 at 5:25 PM
SHARHOLDER ALERT: Block & Leviton LLP Announces It Has Filed A Class Action Against MiMedx Group, Inc. (MDXG)SHARHOLDER ALERT: Block & Leviton LLP Announces It Has Filed A Class Action Against MiMedx Group, Inc. (MDXG)
finance.yahoo.com - April 6 at 5:25 PM
MiMedx Group (MDXG) Receives Buy Rating from Needham & Company LLCMiMedx Group (MDXG) Receives Buy Rating from Needham & Company LLC
www.americanbankingnews.com - April 4 at 12:34 AM
MiMedx Group (MDXG) and Cardiovascular Systems (CSII) Financial ComparisonMiMedx Group (MDXG) and Cardiovascular Systems (CSII) Financial Comparison
www.americanbankingnews.com - April 3 at 11:38 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXGEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXG
finance.yahoo.com - April 2 at 5:13 PM
MDXG INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf ...MDXG INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf ...
www.businesswire.com - March 30 at 5:16 PM
MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The ...MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The ...
www.prnewswire.com - March 30 at 5:16 PM
MDXG INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of MiMedx Group Inc. InvestorsMDXG INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of MiMedx Group Inc. Investors
finance.yahoo.com - March 30 at 5:16 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXGSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXG
finance.yahoo.com - March 29 at 5:15 PM
MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The KneeMiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee
finance.yahoo.com - March 28 at 8:47 AM
MiMedx Group, Inc. (MDXG) Short Interest Up 11.0% in MarchMiMedx Group, Inc. (MDXG) Short Interest Up 11.0% in March
www.americanbankingnews.com - March 28 at 1:40 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXGEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXG
finance.yahoo.com - March 27 at 8:48 AM
Are Options Traders Betting on a Big Move in MiMedx Group (MDXG) Stock?Are Options Traders Betting on a Big Move in MiMedx Group (MDXG) Stock?
www.msn.com - March 26 at 5:04 PM
MiMedxs AmnioFix shows positive effect in mid-stage study in plantar fasciitis; shares ahead 4%MiMedx's AmnioFix shows positive effect in mid-stage study in plantar fasciitis; shares ahead 4%
seekingalpha.com - March 26 at 5:04 PM
SHAREHOLDER ALERT: Spector, Roseman & Kodroff, P.C. Announces Class Action Lawsuit Filed Against MiMedx Group, Inc.SHAREHOLDER ALERT: Spector, Roseman & Kodroff, P.C. Announces Class Action Lawsuit Filed Against MiMedx Group, Inc.
finance.yahoo.com - March 26 at 5:04 PM
The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - March 25 at 6:02 PM
MiMedx Group (MDXG) Downgraded by BidaskClub to "Sell"MiMedx Group (MDXG) Downgraded by BidaskClub to "Sell"
www.americanbankingnews.com - March 24 at 8:23 PM
MiMedx Group, Inc. (MDXG) Given Average Rating of "Hold" by BrokeragesMiMedx Group, Inc. (MDXG) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 24 at 12:26 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXGEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXG
finance.yahoo.com - March 23 at 5:25 PM
Wolf Haldenstein: MiMedx Investor ReminderWolf Haldenstein: MiMedx Investor Reminder
finance.yahoo.com - March 23 at 5:25 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. (Nasdaq: MDXG) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. (Nasdaq: MDXG) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - March 23 at 5:25 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx ... - PR Newswire (press release)SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx ... - PR Newswire (press release)
www.prnewswire.com - March 21 at 9:20 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline -- MDXGSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline -- MDXG
finance.yahoo.com - March 21 at 9:20 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXGINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXG
finance.yahoo.com - March 20 at 5:04 PM
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of MiMedx Group Inc. Shareholders and a Lead Plaintiff Deadline of April 25, 2018
finance.yahoo.com - March 19 at 5:05 PM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline – MDXGSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline – MDXG
feeds.benzinga.com - March 17 at 9:33 AM
MDXG EQUITY ALERT: The Law Offices of Vincent Wong Reminds ... - Business Wire (press release)MDXG EQUITY ALERT: The Law Offices of Vincent Wong Reminds ... - Business Wire (press release)
www.businesswire.com - March 17 at 8:47 AM
MIMEDX GROUP LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP ... - PR Newswire (press release)MIMEDX GROUP LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP ... - PR Newswire (press release)
www.prnewswire.com - March 17 at 8:47 AM
MiMedx Group (MDXG) Downgraded by BidaskClub to SellMiMedx Group (MDXG) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - March 16 at 11:00 PM
MiMedx Group (MDXG) Expects to Exceed the $92 Million Top End of First Quarter RevenueMiMedx Group (MDXG) Expects to Exceed the $92 Million Top End of First Quarter Revenue
www.streetinsider.com - March 16 at 6:12 PM

SEC Filings

MiMedx Group (NASDAQ:MDXG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MiMedx Group (NASDAQ:MDXG) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MiMedx Group (NASDAQ MDXG) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.